Drug intelligence / Profile preview

isoleucine-tryptophan dipeptide

Development stage
Preclinical
Modality
Small Molecules, Peptides
Administration
Oral
01

Overview

Isoleucine-tryptophan dipeptide is a synthetic or naturally derived peptide composed of the amino acids isoleucine and tryptophan. It has been studied for its antihypertensive and cardioprotective effects. Mechanistically, it acts as a potent inhibitor of angiotensin-converting enzyme (ACE), with an in vitro IC50 of 0.7 μM. In animal models (spontaneously hypertensive rats), administration of this dipeptide significantly reduced systolic blood pressure and myocardial mass compared to controls. It also blunted tissue ACE activity, reduced matrix metalloproteinase-2 activity (MMP-2), improved coronary flow reserve, and decreased plasma ACE activity. These effects suggest potential utility as a functional food additive or nutraceutical for attenuating hypertension and providing cardiovascular protection[1][4][7].

Other names
isoleucyltryptophanIsoleucine-Tryptophan dipeptideIsoleucine Tryptophan dipeptideN-TryptophylisoleucineL-TRYPTOPHYL-L-ISOLEUCINEL-Tryptophanyl-L-isoleucine
02

Targets

ACE (Angiotensin Converting Enzyme)MMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on isoleucine-tryptophan dipeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isoleucine-tryptophan dipeptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call